Overview of present day treatment of Parkinson's disease-Reference-Cited by-同舟云学术

Overview of present day treatment of Parkinson's disease

Published:1978-09 Issue:3-4 Volume:43 Page:227-238
ISSN:0300-9564
Container-title:Journal of Neural Transmission
language:en
Short-container-title:J. Neural Transmission

Author:

Yahr M. D.

Publisher

Springer Science and Business Media LLC

Subject

Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/BF01246959.pdf

Reference9 articles.

1. Yahr, M. D. Evaluation of long-term therapy in Parkinson's disease: Mortality and therapeutic efficacy. In: Advances in Parkinsonism (Blrkmayer, W., Hornykiewicz, O., eds.), pp. 435?443. Basle: Editiones Roche. 1976.

2. Marsden, C. D., Parkes, J. D. Lanceti, 345 (1977).

3. Lloyd, K. G., Davidson, L., Hornykiewicz, O. The neurochemistry of Parkinson's disease: Effect of L-Dopa therapy. J. Pharmacol. and Exper. Ther.195, 453?464 (1975).

4. Yahr, M. D. Variations in the ?on-off? effect. Adv. Neurol.5, 397 to 404 (1974).

5. CIBA Foundation Symposium 39 (new series);J. Knoll,1976

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trace level Quantification of N-Nitroso Safinamide: A Genotoxic Impurity in Safinamide Mesylate Using ESI-MS/MS;Research Journal of Pharmacy and Technology;2024-04-22

2. Increased Levels of Pro-Inflammatory and Anti-Inflammatory Cellular Responses in Parkinson’s Disease Patients: Search for a Disease Indicator;Medical Science Monitor;2017-06-18

3. Behavioral pharmacology of orofacial movement disorders;International Review of Neurobiology;2011

4. UPDATE ON THE MEDICAL MANAGEMENT OF PARKINSON DISEASE;CONTINUUM: Lifelong Learning in Neurology;2010-02

5. Selegiline in Parkinson's disease;Acta Neurologica Scandinavica;2009-01-29